At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Device: Cryo-Touch III Study treatment at Day 0.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Non-Randomized Unblinded Study Evaluating the Treatment of Occipital Neuralgia With the Cryo-Touch III Device
In Brief
A clinical study evaluating Device: Cryo-Touch III Study treatment at Day 0. for Occipital Neuralgia. Completed, enrolled 26 participants across 3 sites.
Detailed Summary
A proof of concept study to evaluate the feasibility of safe and effective treatment through optimization of the Cryo-Touch III device for temporary relief of or reduction in pain due to occipital neuralgia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOccipital Neuralgia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedDec 2012
Primary CompletionDec 2013
Study CompletionJul 2014
TodayJul 2026
First PostedDec 20, 2012
Enrollment StartOct 1, 2012
Primary CompletionDec 1, 2013
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.5 years ago
Interventions
Device: Cryo-Touch III Study treatment at Day 0.device
Device: Cryo-Touch III Study treatment at Day 0.